Notification That Annual Report Will Be Submitted Late (nt 10-k)
03 November 2017 - 3:59PM
Edgar (US Regulatory)
|
|
UNITED
STATES
|
|
|
|
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
|
|
|
|
|
|
|
|
FORM
12b-25
|
SEC FILE NUMBER
333-59114
|
|
|
|
|
|
|
NOTIFICATION OF LATE FILING
|
CUSIP NUMBER
02265L109
|
(Check
one):
[X] Form 10-K [ ] Form 20-F [ ] Form
11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form
N-CSR
|
|
For
Period Ended:
|
June
30, 2017
|
|
[ ] Transition
Report on Form 10-K
[ ] Transition
Report on Form 20-F
[ ] Transition
Report on Form 11-K
[ ] Transition
Report on Form 10-Q
[ ] Transition
Report on Form N-SAR
|
|
For
the Transition Period Ended:
|
|
|
|
Nothing
in this form shall be construed to imply that the Commission has verified any information contained herein.
|
If
the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART
I — REGISTRANT INFORMATION
Amaize
Beverage Corporation
Full
Name of Registrant
Former
Name if Applicable
5042
Wilshire Blvd., 34708
Address
of Principal Executive Office
(Street and Number)
Los
Angeles, CA 90036
City,
State and Zip Code
PART
II — RULES 12b-25(b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule
12b-25(b), the following should be completed. (Check box if appropriate)
|
SEC
1344 (04 09)
|
Persons
who are to respond to the collection of information contained in this form are not required to respond unless the form displays
a currently valid OMB control number.
|
|
[ ]
|
(a)
|
The
reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
|
|
|
|
|
|
[X]
|
(b)
|
The
subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR,
or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject
quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be
filed on or before the fifth calendar day following the prescribed due date; and
|
|
|
|
|
|
[ ]
|
(c)
|
The
accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART
III — NARRATIVE
State
below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof,
could not be filed within the prescribed time period.
The
compilation, dissemination and review of the information required to be presented in the Form 10-K for the period ending June
30, 2016 could not be completed without undue hardship and expense to the registrant. The registrant anticipates that it
will file its Form 10-K for the year ended June 30, 2017 within the “grace” period provided by Securities
Exchange Act Rule 12b-25.
(Attach
extra Sheets if Needed)
PART
IV — OTHER INFORMATION
|
(1)
|
Name
and telephone number of person to contact in regard to this notification
|
|
|
Richard
Damion, CEO
|
(949)
|
287-3164
|
|
|
(Name)
|
(Area
Code)
|
(Telephone
Number)
|
|
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required
to file such report(s) been filed ? If answer is no, identify report(s).
|
|
(3)
|
Is
it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year
will be reflected by the earnings statements to be included in the subject report or portion thereof?
|
If
so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons
why a reasonable estimate of the results cannot be made.
Amaize
Beverage Corporation
(Name
of Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date:
|
October
29, 2017
|
|
By:
|
/s/
Richard Damion
|
|
|
|
|
Name:
|
Richard
Damion
|
|
|
|
|
Title:
|
CEO
|
|
ATTENTION
Intentional
misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).
|
Curative Biosciences (CE) (USOTC:CBDX)
Historical Stock Chart
Von Okt 2024 bis Nov 2024
Curative Biosciences (CE) (USOTC:CBDX)
Historical Stock Chart
Von Nov 2023 bis Nov 2024
